449 related articles for article (PubMed ID: 28421461)
1. The role of tumor board conferences in neuro-oncology: a nationwide provider survey.
Snyder J; Schultz L; Walbert T
J Neurooncol; 2017 May; 133(1):1-7. PubMed ID: 28421461
[TBL] [Abstract][Full Text] [Related]
2. Tumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer Centers.
Mori S; Navarrete-Dechent C; Petukhova TA; Lee EH; Rossi AM; Postow MA; Dunn LA; Roman BR; Yin VT; Coit DG; Hollmann TJ; Busam KJ; Nehal KS; Barker CA
J Natl Compr Canc Netw; 2018 Oct; 16(10):1209-1215. PubMed ID: 30323091
[No Abstract] [Full Text] [Related]
3. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
4. Is there a role for clinical practice guidelines in multidisciplinary tumor board meetings? A descriptive study of knowledge transfer between research and practice.
Kostaras X; Shea-Budgell MA; Malcolm E; Easaw JC; Roa W; Hagen NA
J Cancer Educ; 2012 Mar; 27(1):42-5. PubMed ID: 21882052
[TBL] [Abstract][Full Text] [Related]
5. Communication in and clinician satisfaction with multidisciplinary team meetings in neuro-oncology.
Field KM; Rosenthal MA; Dimou J; Fleet M; Gibbs P; Drummond K
J Clin Neurosci; 2010 Sep; 17(9):1130-5. PubMed ID: 20570520
[TBL] [Abstract][Full Text] [Related]
6. The Latin American Brain Tumor Board teleconference: results of a web-based survey to evaluate participant experience utilizing this resource.
Abu Arja MH; Stanek JR; Morales La Madrid AE; Lassaletta A; Bartels U; Qaddoumi I; Finlay JL; Osorio DS
Childs Nerv Syst; 2019 Feb; 35(2):257-265. PubMed ID: 30426208
[TBL] [Abstract][Full Text] [Related]
7. The Emergence of Virtual Tumor Boards in Neuro-Oncology: Opportunities and Challenges.
Ekhator C; Kesari S; Tadipatri R; Fonkem E; Grewal J
Cureus; 2022 Jun; 14(6):e25682. PubMed ID: 35677741
[TBL] [Abstract][Full Text] [Related]
8. A single-institution prospective evaluation of a neuro-oncology multidisciplinary team meeting.
Ameratunga M; Miller D; Ng W; Wada M; Gonzalvo A; Cher L; Gan HK
J Clin Neurosci; 2018 Oct; 56():127-130. PubMed ID: 30318071
[TBL] [Abstract][Full Text] [Related]
9. The role of molecular tumor boards in neuro-oncology: a nationwide survey.
Hönikl LS; Lange S; Butenschoen VM; Delbridge C; Meyer B; Combs SE; Illert AL; Schmidt-Graf F
BMC Cancer; 2024 Jan; 24(1):108. PubMed ID: 38243190
[TBL] [Abstract][Full Text] [Related]
10. Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey.
Schäfer N; Bumes E; Eberle F; Fox V; Gessler F; Giordano FA; Konczalla J; Onken J; Ottenhausen M; Scherer M; Schneider M; Vatter H; Herrlinger U; Schuss P
J Neurooncol; 2021 Jul; 153(3):479-485. PubMed ID: 34115248
[TBL] [Abstract][Full Text] [Related]
11. Survey of long-term follow-up programs in the United States for survivors of childhood brain tumors.
Bowers DC; Adhikari S; El-Khashab YM; Gargan L; Oeffinger KC
Pediatr Blood Cancer; 2009 Dec; 53(7):1295-301. PubMed ID: 19688835
[TBL] [Abstract][Full Text] [Related]
12. Challenges and opportunities to advance pediatric neuro-oncology care in the developing world.
Chan MH; Boop F; Qaddoumi I
Childs Nerv Syst; 2015 Aug; 31(8):1227-37. PubMed ID: 26040936
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.
Ansari M; Mosalaei A; Ahmadloo N; Rasekhi A; Geramizadeh B; Razmkon A; Anvari K; Afarid M; Dadras A; Nafarieh L; Mohammadianpanah M; Nasrolahi H; Hamedi SH; Omidvari S; Nami M
Ger Med Sci; 2017; 15():Doc05. PubMed ID: 28325997
[TBL] [Abstract][Full Text] [Related]
14. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
15. Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer.
Ung KA; Campbell BA; Duplan D; Ball D; David S
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e298-304. PubMed ID: 24674013
[TBL] [Abstract][Full Text] [Related]
16. The role of oncologists in multidisciplinary cancer teams in the UK: an untapped resource for team leadership?
Lamb B; Payne H; Vincent C; Sevdalis N; Green JS
J Eval Clin Pract; 2011 Dec; 17(6):1200-6. PubMed ID: 20666886
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Pediatric Neuro-Oncology Resources Available in Chile.
Abu-Arja MH; Rojas Del Río N; Morales La Madrid A; Lassaletta A; Coven SL; Moreno R; Valero M; Perez V; Espinoza F; Fernandez E; Santander J; Tordecilla J; Oyarce V; Kopp K; Bartels U; Qaddoumi I; Finlay JL; Cáceres A; Reyes M; Espinoza X; Osorio DS
JCO Glob Oncol; 2021 Mar; 7():425-434. PubMed ID: 33788596
[TBL] [Abstract][Full Text] [Related]
18. The position of the neurologist in neuro-oncology.
Grisold W; Heimans JJ; Postma TJ; Grant R; Soffietti R;
Eur J Neurol; 2002 May; 9(3):201-5. PubMed ID: 11985627
[TBL] [Abstract][Full Text] [Related]
19. [NEURO-ONCOLOGY A NEW FIELD IN DAVIDOFF CANCER CENTER AT RABIN MEDICAL CENTER].
Yust-Katz S; Limon D; Abu-Shkara R; Siegal T
Harefuah; 2017 Aug; 156(8):512-516. PubMed ID: 28853528
[TBL] [Abstract][Full Text] [Related]
20. Editorial: advances in neuro-oncology and clinical treatment-from ASNO 2019.
Chen PY; Wei KC
J Neurooncol; 2020 Feb; 146(3):397-398. PubMed ID: 32020469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
